Compound Detail
CHEMBL502563
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC1=C(C)C(=O)O[C@@H]([C@](C)(O)[C@]2(O)CC[C@@]3(O)[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1
Basic Information
| ChEMBL ID | CHEMBL502563 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UPBUGICUKQIKTJ-KABTZXSUSA-N |
5
Targets
6
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
502.6
MW (Da)
1.73
ALogP
8
HBA
4
HBD
136.8
PSA (Ų)
0.33
QED
1
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 7.4
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 40.0 | nM | 7.4 | Inhibition of TNFalpha-activated nuclear factor-kappa B activity (unknown origin... | 27210437 |
| CWR22R | IC50 | = | 90.0 | nM | 7.05 | Cytotoxicity against human 22Rv1 cells assessed as reduction in cell viability a... | 28617598 |
| LNCaP | IC50 | = | 160.0 | nM | 6.8 | Cytotoxicity against human LNCAP cells assessed as reduction in cell viability a... | 28617598 |
| RAW264.7 | IC50 | = | 320.0 | nM | 6.5 | Inhibition of lipopolysaccharide-induced nitric oxide production in mouse RAW264... | 27210437 |
| ACHN | IC50 | = | 563.0 | nM | 6.25 | Sensitization of TRAIL-induced apoptosis in human ACHN cells assessed as reducti... | 28257574 |
| RAW264.7 | IC50 | = | 1800.0 | nM | 5.75 | Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of... | 30649869 |
Literature References
Data from ChEMBL 36 via Core Engine